JP Morgan Chase
MNTA

JP Morgan Chase’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

JP Morgan Chase’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,500
Closed -$482K – 5992
2020
Q2 		$482K Buy
+14,500
New +$462K ﹤0.01% 3868

JP Morgan Chase's MNTA Position: Q4 2020 in Review

JP Morgan Chase sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,461,262 shares — an estimated $76.7M sold.

JP Morgan Chase first reported a position in MNTA in Q2 2013 and held it in 25 quarters. The position peaked at $76.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • JP Morgan Chase reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 1,461,262 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $76.7M.
  • JP Morgan Chase first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 25 quarters.
  • JP Morgan Chase's Momenta Pharmaceuticals, Inc. position peaked at $76.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.